Term ended Aug 16, 2026 · High confidence

Computed 20-year base term

Held by Janssen Biotech, Inc.

Filed Dec 4, 2013 as application 14/096,596 · Granted May 17, 2016

Base term plus 110 days of patent term adjustment (USPTO delay)

Today

20 years from filing

Term ended Aug 16, 2026

2006 2026

Clock starts
Apr 28, 2006

Term ended
Aug 16, 2026

Granted
May 17, 2016

base term patent term adjustment after the term ends fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

110

Days of term adjustment

Read from the USPTO patent term adjustment record, not recalculated here.

None

Terminal disclaimer

No disclaimer on this record.

2 of 2

Maintenance fees paid

Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.

Family applications on record here

Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 110 days past its 20-year base term on prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.

Step	Input	Date after this step	Confidence
Base term, 20 years from filing	Clock starts Apr 28, 2006, when application 11/413,561, the earliest non-provisional in its chain, was filed (this one was filed Dec 4, 2013)	Apr 28, 2026	High confidence
Continuity chain	Every parent in the chain resolved	no change	High confidence
Patent term adjustment	+110 days, USPTO patent term adjustment record	Aug 16, 2026	High confidence
Terminal disclaimer cap	None on record	no cap applied	High confidence
Patent term extension	None on file	no change	High confidence
Fee events	2 of 2 maintenance fees paid	term ended	High confidence
Computed term end	The steps above, in order	Aug 16, 2026	High confidence

This family

US 7,560,112	Surrendered on reissue Sep 2012	Sep 2012
US 7,833,755	Term ended Apr 2026	Apr 2026
US 8,067,003	Term ended Apr 2026	Apr 2026
US RE43,672	In force Apr 2027	Apr 2027
US 8,226,611	Term ended Apr 2026	Apr 2026
US 8,623,362	Term ended no later than Apr 2026	no later than Apr 2026
US 9,340,613	this patent Aug 2026	Aug 2026
US 9,631,016	Term ended Apr 2026	Apr 2026

8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.

Recorded	Assignor	Assignee	Conveyance
Jan 31, 2019 Reel 48223, frame 122	Centocor Ortho Biotech Inc.	Janssen Biotech, Inc.	Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

What's changing

Note

The 110 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us

Citations

later US patents cite this one

That is top 10% of utility patents granted in 2016 in our data, the only group it is compared against. How we rank

Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Anti-IL-6 Antibodies, Compositions, Methods and Uses